A Phase 2, Double-blind, Randomized, Placebo-controlled Milticenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Administered By
Awarded By
Contributors
- Clowse, Megan Elizabeth Bowles Principal Investigator
Start/End
- January 1, 2017 - October 31, 2019